{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:37:38Z","timestamp":1790095058362,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.xjidi.2025.100375","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T19:51:35Z","timestamp":1746474695000},"page":"100375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Tape Strip Profiling of Checkpoint Inhibitor\u2013Associated Dermatitis Highlights Pan-T-Cell Activation: A Pilot Study"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-0566","authenticated-orcid":false,"given":"Camille M.","family":"Powers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8108-3631","authenticated-orcid":false,"given":"Madeline","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4692-6338","authenticated-orcid":false,"given":"Annie","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-0109","authenticated-orcid":false,"given":"Benjamin D.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-6969","authenticated-orcid":false,"given":"Brandon R.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8922-6545","authenticated-orcid":false,"given":"Austin J.","family":"Piontkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8595-6196","authenticated-orcid":false,"given":"Jeremy","family":"Orloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade N.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5172-6747","authenticated-orcid":false,"given":"Yeriel D.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6908-2211","authenticated-orcid":false,"given":"Digpal S.","family":"Gour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9363-324X","authenticated-orcid":false,"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4347-0710","authenticated-orcid":false,"given":"Nicholas","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2025.100375_bib1","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/cancers16061226","article-title":"T-cell subtypes and immune signatures in cutaneous immune-related adverse events in melanoma patients under immune checkpoint inhibitor therapy","volume":"16","author":"Absmaier-Kijak","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xjidi.2025.100375_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7370","article-title":"Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma","volume":"13","author":"Alnemri","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.xjidi.2025.100375_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2025.100375_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/cup.13454","article-title":"Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response","volume":"46","author":"Curry","year":"2019","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.xjidi.2025.100375_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-023-06217-y","article-title":"PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens","volume":"619","author":"Damo","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xjidi.2025.100375_bib6","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/all.16060","article-title":"Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities","volume":"79","author":"Del Duca","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.xjidi.2025.100375_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/all.15845","article-title":"Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsies","volume":"79","author":"Del Duca","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.xjidi.2025.100375_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2014.03.009","article-title":"Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response","volume":"134","author":"Dhingra","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2025.100375_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xjidi.2025.100375_bib10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaip.2024.11.015","article-title":"Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: a national database analysis","volume":"13","author":"Garate","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.xjidi.2025.100375_bib11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jaad.2020.03.132","article-title":"Immune checkpoint inhibitor-related dermatologic adverse events","volume":"83","author":"Geisler","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2025.100375_bib12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ccell.2020.08.005","article-title":"Conserved interferon-\u03b3 signaling drives clinical response to immune checkpoint blockade therapy in melanoma","volume":"38","author":"Grasso","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xjidi.2025.100375_bib13","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1177\/10781552241269712","article-title":"Successful treatment of PD1-inhibitor induced psoriasiform dermatitis using IL-17 blockade without compromising immunotherapy efficacy","volume":"30","author":"Greene","year":"2024","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.xjidi.2025.100375_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.xjidi.2025.100375_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003551","article-title":"Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition","volume":"10","author":"Henderson Berg","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.xjidi.2025.100375_bib16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.xjidi.2025.100375_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2326-6066.CIR-18-0682","article-title":"IL17A blockade successfully treated psoriasiform dermatologic toxicity from immunotherapy","volume":"7","author":"Johnson","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.xjidi.2025.100375_bib18","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.jid.2022.03.022","article-title":"Transcriptomic analysis of the major orphan ichthyosis subtypes reveals shared immune and barrier signatures","volume":"142","author":"Kim","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2025.100375_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-023-06797-9","article-title":"An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis","volume":"625","author":"LaMarche","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xjidi.2025.100375_bib20","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.9005.1","article-title":"RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR","volume":"5","author":"Law","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.xjidi.2025.100375_bib21","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.xjidi.2025.100375_bib22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1186\/s12864-015-2270-1","article-title":"Comprehensive evaluation of AmpliSeq transcriptome, a novel targeted whole transcriptome RNA sequencing methodology for global gene expression analysis","volume":"16","author":"Li","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.xjidi.2025.100375_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004308","article-title":"Successful management of pre-existing psoriatic arthritis through targeting the IL-23\/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case series","volume":"10","author":"Li","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.xjidi.2025.100375_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.xjidi.2025.100375_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1186\/s12967-024-05617-6","article-title":"Tofacitinib for the treatment of immune-related adverse events in cancer immunotherapy: a multi-center observational study","volume":"22","author":"Liu","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.xjidi.2025.100375_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jdin.2023.11.013","article-title":"Checkpoint inhibitor-induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level","volume":"15","author":"Meier-Schiesser","year":"2024","journal-title":"JAAD Int"},{"key":"10.1016\/j.xjidi.2025.100375_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamaoncol.2021.4318","article-title":"Management of cutaneous immune-related adverse events in patients with cancer treated with immune checkpoint inhibitors: a systematic review","volume":"8","author":"Nadelmann","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.xjidi.2025.100375_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2023.11.048","article-title":"Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa","volume":"90","author":"Navrazhina","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2025.100375_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72111-6","article-title":"Tape stripping method is useful for the quantification of antimicrobial peptides on the human skin surface including the stratum corneum","volume":"10","author":"Ono","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.xjidi.2025.100375_bib30","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jaip.2022.12.018","article-title":"No association between dupilumab use and short-term cancer development in atopic dermatitis patients","volume":"11","author":"Owji","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.xjidi.2025.100375_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s40257-024-00866-z","article-title":"The use of biologic agents for the treatment of cutaneous immune-related adverse events from immune checkpoint inhibitors: a review of reported cases","volume":"25","author":"Pach","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.xjidi.2025.100375_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2336118","article-title":"Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report","volume":"35","author":"Powers","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.xjidi.2025.100375_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaad.2020.09.054","article-title":"Cutaneous adverse events caused by immune checkpoint inhibitors","volume":"85","author":"Quach","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2025.100375_bib34","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/2326-6066.CIR-22-0362","article-title":"Checkpoint blockade-induced dermatitis and colitis are dominated by tissue-resident Memory T Cells and Th1\/Tc1 cytokines","volume":"10","author":"Reschke","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.xjidi.2025.100375_bib35","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xjidi.2025.100375_bib36","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.3390\/curroncol30070498","article-title":"Molecular mechanisms of cutaneous immune-related adverse events (irAEs) induced by immune checkpoint inhibitors","volume":"30","author":"Teng","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.xjidi.2025.100375_bib37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","article-title":"Cellular and molecular immunologic mechanisms in patients with atopic dermatitis","volume":"138","author":"Werfel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2025.100375_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026725000311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026725000311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:36:47Z","timestamp":1762641407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026725000311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2667026725000311"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2025.100375","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tape Strip Profiling of Checkpoint Inhibitor\u2013Associated Dermatitis Highlights Pan-T-Cell Activation: A Pilot Study","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2025.100375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100375"}}